Glucagon receptor antagonist compounds
US8445538B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2009 |
| Grant date | May 21, 2013 |
| Priority date | — |
| Expiry date | May 27, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C323/62
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.